Protalix BioTherapeutics, Inc. (NYSEMKT:PLX)

CAPS Rating: 2 out of 5

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

159 Outperform
73 Underperform
 

All-Star Players

16 Outperform
22 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (83.81)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

PLX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 PLX Score: -92.77

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 PLX Score: -138.62

IHS pattern

Recs

1
Member Avatar TMFBiologyFool (83.81) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 PLX Score: +180.16

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

1or5stars

1or5stars (99.74) Score: +292.55

The Score Leader is the player with the highest score across all their picks in PLX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.74 2/10/2009 Underperform 3W $2.66 -85.30% +207.25% +292.55 0 Comment
anticitradeshort 34.26 4/20/2009 Underperform NS $2.27 -82.78% +207.67% +290.45 0 Comment
Spelunkin 77.33 11/3/2009 Underperform 5Y $10.39 -96.24% +151.08% +247.32 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -96.05% +150.14% +246.19 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -96.05% +150.14% +246.19 0 Comment
ModernDayWarrior 22.16 10/29/2009 Underperform 5Y $9.58 -95.92% +147.62% +243.54 0 Comment
mathieugp 24.78 9/28/2009 Underperform 3M $7.87 -95.03% +148.42% +243.45 0 Comment
MSFOBV1YH 97.83 11/4/2009 Underperform 5Y $10.93 -96.42% +146.87% +243.29 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -96.71% +145.13% +241.84 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -96.74% +141.29% +238.03 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJPMorgan 87.03 10/21/2013 Outperform NS $4.66 -91.61% +49.31% -140.92 0 Comment
TrackUltraLong < 20 11/9/2011 Underperform NS $6.31 -93.80% +108.56% +202.36 1 Comment
trackwbbsecuriti < 20 3/17/2011 Outperform NS $6.33 -93.82% +103.49% -197.32 0 Comment
TrackZacks < 20 2/28/2011 Underperform 3M $7.05 -30.50% +3.76% +34.26 11/9/2012 @ $4.90 1 Comment
TrackOppenheimer 66.38 11/9/2010 Outperform NS $9.68 -95.96% +112.07% -208.04 0 Comment
TrackCanaccord 68.95 9/23/2009 Outperform NS $7.55 -94.82% +143.25% -238.07 0 Comment
trackhapoalim < 20 9/2/2009 Outperform NS $6.85 -94.29% +162.28% -256.57 0 Comment
TrackUBS 91.95 3/11/2008 Outperform NS $2.82 -86.13% +107.65% -193.79 0 Comment

Advertisement